Lineage Cell Therapeutics, Inc.
LCTX
Revenue
2.87M
▼-911.00k▼-24.11%
3 Months ChangeAssets
113.22M
▲16.62M▲17.21%
3 Months ChangeLiabilities
36.21M
▲4.41M▲13.86%
3 Months ChangeFree Cash Flow
-5.82M
▲5.61M▲49.07%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-08
Form 10-Q
ID: 0000950170-24-094004
2024-08-08
Form 8-K
ID: 0000950170-24-093947
2024-06-14
Form 8-K
ID: 0000950170-24-073769
2024-06-13
Form 8-K
ID: 0000950170-24-073072
2024-05-14
Form 8-K
ID: 0000950170-24-059689
2024-05-09
Form 10-Q
ID: 0000950170-24-056998
2024-05-09
Form 8-K
ID: 0000950170-24-056948
2024-03-22
Form 8-K
ID: 0000950170-24-035365
2024-03-07
Form 8-K
ID: 0000950170-24-027951
2024-02-15
Form 8-K
ID: 0001493152-24-006901